Advancing Translation of Long-Acting Strategies for HIV and HIV-Associated Co-infections (AT LASt) (R61/R33 Clinical Trial Not Allowed) Expires: March 14, 2025

Open Date (Earliest Submission Date): February 13, 2025

Expiration Date: March 14, 2025


Funds Available and Anticipated Number of Awards
NIAID intends to commit an estimated total of $4,000,000 in FY 2026 to fund 3-5 awards.

Award Budget
Application budgets are not expected to exceed $700,000 in direct costs less consortium indirect (F&A) per year during the R61 Phase and $1,000,000 in direct costs less consortium indirect (F&A) per year during the R33 Phase. Requested budgets should reflect the actual needs of the proposed project.

Award Project Period
Applicants may request up to two years of support for the R61 phase, and up to three years of support for the R33 phase. The maximum project period for an application submitted in response to this NOFO cannot exceed five years total.

 

Find additional information here